STALICLA
Precision medicine for NDDs
- B2B
About STALICLA
A Swiss biopharmaceutical company specializing in precision medicine for neurodevelopmental disorders, using omics-based technology to develop tailored treatments
Key facts
- Industry
- Biotechnology Research
- Company size
- 11–50 employees
- Headquarters
- Genève, Switzerland
- Founded
- 2017
- Revenue
- $9.9M – $77.8MTamtam estimate
- Website
- stalicla.com
- linkedin.com/company/stalicla
STALICLA at a glance
STALICLA is a B2B company in the Biotechnology Research industry, headquartered in Genève, Switzerland.
STALICLA was founded in 2017.
STALICLA has 11–50 employees.
STALICLA's revenue is $9.9M – $77.8M (Tamtam estimate).
Selling to companies like STALICLA?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies